Maravai Lifesciences Holdings (MRVI) Gross Margin Growth (3y) (2023 - 2026)

Maravai Lifesciences Holdings (MRVI) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Maravai Lifesciences Holdings 1.03 Bn 1.02 Bn 33.70 Mn -620.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -620.00
Dec 31, 2025 -4,823.00
Sep 30, 2025 -6,646.00
Jun 30, 2025 -6,816.00
Mar 31, 2025 -6,712.00
Dec 31, 2024 -4,858.00
Sep 30, 2024 -3,757.00
Jun 30, 2024 -3,821.00
Mar 31, 2024 -3,855.00
Dec 31, 2023 -2,357.00
Sep 30, 2023 -3,238.00
Jun 30, 2023 -1,760.00
Mar 31, 2023 -1,261.00